These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 332190)

  • 1. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
    Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the influence of vincamine on human cerebral blood flow in the acute test. Studies with 133Xe clearance method (author's transl)].
    Kohlmeyer K
    Arzneimittelforschung; 1977; 27(6a):1285-90. PubMed ID: 578454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T; Passeri F; Locatelli F
    Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M; Magnani G; Sinforiani E; Casali R
    Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
    Bartels H
    MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H
    Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L; Bruck J; Tschabitscher H
    Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
    [No Abstract]   [Full Text] [Related]  

  • 18. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T
    Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
    Bartels H
    Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.